Aldeyra Therapeutics Inc. (NASDAQ: ALDX)
$4.6900
-0.0200 ( -0.43% ) 334.3K
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated diseases. The company's product candidate, reproxalap, is a first-in-class treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer.
Market Data
Open
$4.6900
Previous close
$4.7100
Volume
334.3K
Market cap
$278.69M
Day range
$4.5160 - $4.7890
52 week range
$1.4200 - $7.8800
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 33 | Dec 19, 2023 |
8-k | 8K-related | 22 | Nov 28, 2023 |
10-q | Quarterly Reports | 69 | Nov 03, 2023 |
8-k | 8K-related | 12 | Nov 01, 2023 |
4 | Insider transactions | 1 | Oct 18, 2023 |
8-k | 8K-related | 12 | Oct 16, 2023 |
4 | Insider transactions | 1 | Sep 11, 2023 |
4 | Insider transactions | 1 | Sep 11, 2023 |
4 | Insider transactions | 1 | Aug 24, 2023 |